snp genotyping by sequenom massarray maldi-tof mass spectrometry (Sequenom)
Structured Review
Snp Genotyping By Sequenom Massarray Maldi Tof Mass Spectrometry, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+maldi-tof+genotyping+system/mass+spectrometry+snp+genotyping+system/bio_rxiv__2025__04__27__649857-385-4-7
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Moderates the Effects of Childhood Abuse on Severity of Depressive Symptoms in a Time-Dependent Manner Article Snippet: In brief, DNA was recovered from stabilized saliva samples and the rs6265 polymorphism was genotyped as part of a larger genotyping project with the Sequenom Article Title: Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: A 5-year prospective cohort study. Article Snippet: Twelve polymorphisms in nine genes along with 60 unlinked ancestry informative markers (AIMs; Supplementary Table S1) were genotyped with the Sequenom Article Title: Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy Article Snippet: Objectives: The aim of this study was to explore the main and interaction effects of the COMT Val158Met, DRD2 C957T, BDNF Val66Met, and APOE polymorphisms on treatment efficacy and cognitive side effects of electroconvulsive therapy (ECT).. Methods: A total of 117 adult inpatients with a diagnosis of major depressive disorder recruited from 3 hospitals were administered the Montgomery-Äsberg Depression Rating Scale and a cognitive battery assessing global cognition, anterograde memory, executive function, speed and concentration, as well as retrograde memory at baseline and after ECT treatment.. Results: DRD2 C957T heterozygotes had 3.7 (95% confidence interval, 1.13–12.25; P = 0.032) greater odds of remission compared with CC homozygotes. Article Title: SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia Article Snippet: Samples were genotyped at Article Title: COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex. Article Snippet: Samples were genotyped for four COMT SNPs and 60 unlinked ancestry informative markers (AIMs) representing three HapMap phase III populations (Northern/Western European, Han Chinese, and Yoruba in Nigeria) with the Article Title: An Interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure. Article Snippet: a Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Carlton South, VIC, Australia b The Cooperative Research Centre (CRC) for Mental Health, VIC, Australia c 1st Department of Psychiatry, Athens University Medical School, Eginition Hospital, Athens, Greece d Schizophrenia Research Laboratory, Neuroscience Research Australia, Barker Street, Sydney, Australia e School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia f Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia g Centre for Neural Engineering, The University of Melbourne, Carlton, VIC, Australia h NorthWestern Mental Health, Melbourne, Victoria, Australia i Institute of Psychiatry, Psychology, and Neuroscience, King's College London, UK j Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada k Departments of Medical Genetics, Psychiatry, and Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada l Department of Neuroscience & Physiology, Upstate Medical University, Syracuse, New York 13210, USA m Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada Article Title: Downregulation of plasma SELENBP1 protein in patients with recent-onset schizophrenia. Article Snippet: Genotyping was performed at the Australian Genome Research Facility (Brisbane, Australia) with the |
